AACR to Honor Three Congressional Leaders with Distinguished Public Service Awards
September 21, 2011
WASHINGTON, D.C. — The American Association for Cancer Research is pleased to recognize three members of Congress with Distinguished Public Service Awards for their commitment and dedication to the conquest of cancer. Sen. Jerry Moran (R-Kan.), Rep. Debbie Wasserman Schultz (D-Fla.) and Rep. Todd Platts (R-Penn.) will each receive this prestigious award during an AACR Congressional reception on Sept. 21, 2011, in Washington, D.C.
“We are deeply grateful for the contributions of these three champions of public health and biomedical and cancer research,” said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. “Their demonstrated support for the National Institutes of Health (NIH) and the National Cancer Institute (NCI) will enable the future scientific advances needed to seize today’s scientific momentum, capitalize on prior investments in cancer research, save countless lives, and spur innovation and economic prosperity for our country and all our citizens.”
All three recipients were chosen by the AACR Science Policy and Legislative Affairs Committee, a distinguished panel of senior scientists who serve as the AACR’s principal means for devising and implementing strategies to influence important biomedical research-related public policy issues.
“Hard fought progress over the past 40 years by the cancer research community now provides unprecedented opportunities to translate critical discoveries into improved patient care,” said AACR President Judy E. Garber, M.D., M.P.H., director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School. However, our ability to exploit these exciting findings for progress in cancer diagnosis, treatment and prevention will depend on a strong commitment by Congress to provide the necessary funding for the NIH and NCI.” Sen. Jerry Moran (R-Kan.)
was elected to the Senate last fall, after representing the first district of Kansas for 14 years in the U.S. House of Representatives. Moran’s appointment this year to the Senate Appropriations Committee and specifically, the Subcommittee on Labor, Health and Human Services, Education, has allowed him to continue the strong support for biomedical research that he demonstrated while serving in the House of Representatives.
The AACR is deeply grateful for Moran’s strong engagement on and interest in the work taking place through the NIH and NCI, and appreciates his efforts to advocate for increased funding through his role as a Senate appropriator, most notably for his sponsorship of an amendment during today’s Senate full committee mark-up of the fiscal year 2012 Labor-HHS-Education Appropriations bill to increase the budget of the NIH by $190 million. Rep. Debbie Wasserman Schultz (D-Fla.)
has been a true champion for early cancer detection and prevention. This was most notably demonstrated through her successful efforts to include a provision in the Patient Protection and Affordable Care Act that directs the Centers for Disease Control and Prevention to develop and implement a national education campaign about the threat breast cancer poses to all young women, with particular attention to high-risk ethnic, cultural and racial groups.
Wasserman Schultz has represented the 20th district of Florida since 2005 in the House of Representatives. She serves on the House Budget Committee, where she has proven to be a powerful advocate for NIH funding and cancer research. The AACR applauds her unwavering commitment to cancer prevention, detection and research. Rep. Todd Platts (R-Penn.)
has demonstrated tremendous leadership on the issue of tobacco and public health, and has worked to ensure adequate funding for the NIH and NCI. The AACR especially applauds his sponsorship of the Family Smoking Prevention and Tobacco Control Act of 2009, which gave the Food and Drug Administration the authority to regulate tobacco products for the first time. Platts has represented the 19th district of Pennsylvania for over a decade, and he holds leadership positions in the Congressional Task Force on Tobacco and Health and the Congressional Heart and Stroke Coalition.
The AACR looks forward to continuing to work with Platts to curb tobacco use and support research at the NIH and the NCI in order to achieve our collective goal of preventing and conquering cancer. Pictured above: AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), Rep. Todd Platts (R-Penn.) and AACR President Judy Garber, M.D., M.P.H.Pictured above: AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), William Dalton, M.D., Ph.D., Rep. Debbie Wasserman Schultz (D-Fla.) and AACR President Judy Garber, M.D., M.P.H.Pictured above: Roy Jensen, M.D., Director of the University of Kansas Cancer Center, AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), Senator Jerry Moran (R-Kan.) and AACR President Judy Garber, M.D., M.P.H.
# # #
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes seven major peer-reviewed journals: Cancer Discovery
; Cancer Research
; Clinical Cancer Research
; Cancer Epidemiology, Biomarkers & Prevention
; Molecular Cancer Therapeutics
; Molecular Cancer Research
; and Cancer Prevention Research
. AACR journals received 20 percent of the total number of citations given to oncology journals in 2010. The AACR also publishes Cancer Today
, a magazine for cancer patients, survivors and their caregivers which provides practical knowledge and new hope for cancer survivors. A major goal of the AACR is to educate the general public and policymakers about the value of cancer research in improving public health, the vital importance of increases in sustained funding for cancer research, and the need for national policies that foster innovation and progress in the field. Media Contact:
(267) 312-8711 Michele.Sharp@aacr.org